<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">35061203</PMID><DateCompleted><Year>2022</Year><Month>04</Month><Day>18</Day></DateCompleted><DateRevised><Year>2022</Year><Month>04</Month><Day>18</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1867-0687</ISSN><JournalIssue CitedMedium="Internet"><Volume>18</Volume><Issue>3</Issue><PubDate><Year>2022</Year><Month>Mar</Month></PubDate></JournalIssue><Title>World journal of pediatrics : WJP</Title><ISOAbbreviation>World J Pediatr</ISOAbbreviation></Journal><ArticleTitle>Limited value of procalcitonin, C-reactive protein, white blood cell, and neutrophil in detecting bacterial coinfection and guiding antibiotic use among children with enterovirus infection.</ArticleTitle><Pagination><StartPage>230</StartPage><EndPage>233</EndPage><MedlinePgn>230-233</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s12519-021-00504-2</ELocationID><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Rui-Mu</ForeName><Initials>RM</Initials><AffiliationInfo><Affiliation>Department of Infectious Diseases, Shenzhen Children's Hospital, Shenzhen, 518038, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tan</LastName><ForeName>Kun</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Infectious Diseases, Shenzhen Children's Hospital, Shenzhen, 518038, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fu</LastName><ForeName>Shu</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Infectious Diseases, Shenzhen Children's Hospital, Shenzhen, 518038, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Deng</LastName><ForeName>Ji-Kui</ForeName><Initials>JK</Initials><Identifier Source="ORCID">0000-0002-0040-1491</Identifier><AffiliationInfo><Affiliation>Department of Infectious Diseases, Shenzhen Children's Hospital, Shenzhen, 518038, China. szsetyydeng@sina.com.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016422">Letter</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>01</Month><Day>21</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>World J Pediatr</MedlineTA><NlmUniqueID>101278599</NlmUniqueID></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000900">Anti-Bacterial Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015415">Biomarkers</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000077740">Procalcitonin</NameOfSubstance></Chemical><Chemical><RegistryNumber>9007-41-4</RegistryNumber><NameOfSubstance UI="D002097">C-Reactive Protein</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000900" MajorTopicYN="N">Anti-Bacterial Agents</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001419" MajorTopicYN="N">Bacteria</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015415" MajorTopicYN="N">Biomarkers</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002097" MajorTopicYN="N">C-Reactive Protein</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D060085" MajorTopicYN="Y">Coinfection</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004769" MajorTopicYN="Y">Enterovirus Infections</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007962" MajorTopicYN="N">Leukocytes</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009504" MajorTopicYN="N">Neutrophils</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000077740" MajorTopicYN="N">Procalcitonin</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>The authors have no conflict of interest to declare. No financial or non-financial benefits have been received or will be received from any party related directly or indirectly to the subject of this article.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>10</Month><Day>8</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>12</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>1</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>4</Month><Day>19</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>1</Month><Day>21</Day><Hour>12</Hour><Minute>18</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>1</Month><Day>21</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35061203</ArticleId><ArticleId IdType="pmc">PMC8898256</ArticleId><ArticleId IdType="doi">10.1007/s12519-021-00504-2</ArticleId><ArticleId IdType="pii">10.1007/s12519-021-00504-2</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>van Rossum A, Wulkan RW, Oudesluys-Murphy AM. Procalcitonin as an early marker of infection in neonates and children. Lancet Infect Dis. 2004;4:620–630. doi: 10.1016/S1473-3099(04)01146-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(04)01146-6</ArticleId><ArticleId IdType="pubmed">15451490</ArticleId></ArticleIdList></Reference><Reference><Citation>Trippella G, Galli L, De Martino M, Lisi C, Chiappini E. Procalcitonin performance in detecting serious and invasive bacterial infections in children with fever without apparent source: a systematic review and meta-analysis. Expert Rev Anti Infect Ther. 2017;15:1041–1057. doi: 10.1080/14787210.2017.1400907.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/14787210.2017.1400907</ArticleId><ArticleId IdType="pubmed">29103336</ArticleId></ArticleIdList></Reference><Reference><Citation>Honda T, Uehara T, Matsumoto G, Arai S, Sugano M. Neutrophil left shift and white blood cell count as markers of bacterial infection. Clin Chim Acta. 2016;457:46–53. doi: 10.1016/j.cca.2016.03.017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cca.2016.03.017</ArticleId><ArticleId IdType="pubmed">27034055</ArticleId></ArticleIdList></Reference><Reference><Citation>Yo CM, Hsieh PB, Lee SM, Wu JM, Chang SM, Tasi KMM, et al. Comparison of the test characteristics of procalcitonin to c-reactive protein and leukocytosis for the detection of serious bacterial infections in children presenting with fever without source: a systematic review and meta-analysis. Ann Emerg Med. 2012;60:591–600. doi: 10.1016/j.annemergmed.2012.05.027.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.annemergmed.2012.05.027</ArticleId><ArticleId IdType="pubmed">22921165</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuo K, Yeh Y, Huang Y, Chen I, Lee C. Understanding physician antibiotic prescribing behavior for children with enterovirus infection. PLoS ONE. 2018;13:e202316.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6128467</ArticleId><ArticleId IdType="pubmed">30192893</ArticleId></ArticleIdList></Reference><Reference><Citation>Duan F, Deng M, Lin Y, Hou X, Gu Y. Significance of procalcitonin and other inflammatory markers in pediatric patients with HFMD. Int J Lab Med. 2015;36:446–448.</Citation></Reference><Reference><Citation>Zhou Y, Cai Z. Application of procalcitonin detection in children with hand, foot, and mouth disease complicated with bacterial infection. Heilongjiang Med J. 2017;41:1111–1113.</Citation></Reference><Reference><Citation>Xu Q, Gao L, Wei H, Hu S, Zhang F, Deng Z, et al. Risk factors of death cases of hand, foot, and mouth disease in Harian province. Chin J Prev Med. 2011;45(10):904–908.</Citation><ArticleIdList><ArticleId IdType="pubmed">22321590</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiong H, Pan F, Nie M, He M. A clinical retrospective analysis about application of antibiotics in treatment of 274 cases of hand, foot, and mouth disease. CN Modern Med. 2011;18:32–33.</Citation></Reference><Reference><Citation>Li X, Ni X, Qian S, Wang Q, Jiang R, Xu W, et al. Chinese guidelines for the diagnosis and treatment of hand, foot and mouth disease (2018 edition) World J Pediatr. 2018;14:437–447. doi: 10.1007/s12519-018-0189-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12519-018-0189-8</ArticleId><ArticleId IdType="pubmed">30280313</ArticleId></ArticleIdList></Reference><Reference><Citation>Chinese Medical Association, Chinese Medical Doctor Association Expert consensus for the diagnosis and management of septic shock (infectious shock) in children (2015) Chin J Pediatr. 2015;53:576–580.</Citation><ArticleIdList><ArticleId IdType="pubmed">26717653</ArticleId></ArticleIdList></Reference><Reference><Citation>Mackenzie I, Woodhouse J. C-reactive protein concentrations during bacteraemia: a comparison between patients with and without liver dysfunction. Intens Care Med. 2006;32:1344–1351. doi: 10.1007/s00134-006-0251-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00134-006-0251-1</ArticleId><ArticleId IdType="pubmed">16799774</ArticleId></ArticleIdList></Reference><Reference><Citation>Sigmund IK, Dudareva M, Watts D, Morgenstern M, Athanasou NA, Mcnally MA. Limited diagnostic value of serum inflammatory biomarkers in the diagnosis of fracture-related infections. Bone Joint J. 2020;102-B:904–911. doi: 10.1302/0301-620X.102B7.BJJ-2019-1739.R1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1302/0301-620X.102B7.BJJ-2019-1739.R1</ArticleId><ArticleId IdType="pubmed">32600147</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>